Rudenski AS - Search Results

1

Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC. O'Rahilly SP, et al. Among authors: rudenski as. Lancet. 1986 Aug 16;2(8503):360-4. doi: 10.1016/s0140-6736(86)90052-8. Lancet. 1986. PMID: 2874367

2

Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment.

Rudenski AS, Hadden DR, Atkinson AB, Kennedy L, Matthews DR, Merrett JD, Pockaj B, Turner RC. Rudenski AS, et al. Diabet Med. 1988 Jan;5(1):36-41. doi: 10.1111/j.1464-5491.1988.tb00938.x. Diabet Med. 1988. PMID: 2964326

3

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Matthews DR, et al. Among authors: rudenski as. Diabetologia. 1985 Jul;28(7):412-9. doi: 10.1007/BF00280883. Diabetologia. 1985. PMID: 3899825

4

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC. Hosker JP, et al. Among authors: rudenski as. Diabetologia. 1985 Jul;28(7):401-11. doi: 10.1007/BF00280882. Diabetologia. 1985. PMID: 3899824

5

The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.

Rudenski AS, Hosker JP, Burnett MA, Matthews DR, Turner RC. Rudenski AS, et al. Metabolism. 1988 Jun;37(6):526-34. doi: 10.1016/0026-0495(88)90167-9. Metabolism. 1988. PMID: 3287091

6

Insulin sensitivity and beta-cell function assessed by C-peptide in young adults with cystic fibrosis.

Davis TM, Batten JC, Rudenski AS, Turner RC. Davis TM, et al. Among authors: rudenski as. Eur J Clin Invest. 1987 Feb;17(1):12-5. doi: 10.1111/j.1365-2362.1987.tb01219.x. Eur J Clin Invest. 1987. PMID: 3106046

7

Pathogenesis of NIDDM--a disease of deficient insulin secretion.

Turner RC, Matthews DR, Clark A, O'Rahilly S, Rudenski AS, Levy J. Turner RC, et al. Among authors: rudenski as. Baillieres Clin Endocrinol Metab. 1988 May;2(2):327-42. doi: 10.1016/s0950-351x(88)80035-1. Baillieres Clin Endocrinol Metab. 1988. PMID: 3075895 Review.

8

The glucose stimulus-response curve of the beta-cell in physically trained humans, assessed by hyperglycemic clamps.

O'Rahilly SO, Hosker JP, Rudenski AS, Matthews DR, Burnett MA, Turner RC. O'Rahilly SO, et al. Among authors: rudenski as. Metabolism. 1988 Oct;37(10):919-23. doi: 10.1016/0026-0495(88)90147-3. Metabolism. 1988. PMID: 3050363

9

The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression.

Matthews DR, Rudenski AS, Burnett MA, Darling P, Turner RC. Matthews DR, et al. Among authors: rudenski as. Clin Endocrinol (Oxf). 1985 Jul;23(1):71-9. doi: 10.1111/j.1365-2265.1985.tb00185.x. Clin Endocrinol (Oxf). 1985. PMID: 2863015

10

Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.

Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC. Hosker JP, et al. Among authors: rudenski as. Metabolism. 1989 Aug;38(8):767-72. doi: 10.1016/0026-0495(89)90064-4. Metabolism. 1989. PMID: 2668699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results